PATENT CLAIM ANALYSIS

Application Number: 16078409
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "299000"]

Abstract:
The invention provides methods for modulating the activity of farnesoid X receptors (FXRs) using specific FXR agonists, in particular for treating or preventing liver diseases.

Claim (Index 6):
The method according to  claim 1 , wherein the FXR agonist compound is Compound A, in free form or an amino acid conjugate thereof.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 96.0
- Lexical Diversity: 1.03571
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16335662', '14909263', '15263033', '16030141', '15139138']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7634084025563855
- 35 USC 102 Novelty (BERT): 0.5122942336274876
- Combined Prediction Score: 0.7382969856634957
- Mean Citation Score: 231.63671
- Max Citation Score: 240.76369
- Similarity Product: 144.65654550513625

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test